Provider

Eden

Item: Eden
Rating: 4.5
Author: halfrx

4.5

halfrx score

Compounded semaglutide at $198 a month, tirzepatide at $298: a $99 membership plus the drug, both on Eden's own page.

All-in, per month

$198–$298

checked 2026-09-13 — no maintenance-dose priceVisit Eden ↗

Medication: compounded
Commitment: month-to-month
Insurance: cash only
Price checked: 2026-09-13

Read from tryeden.com/weight-loss on 13 September 2026: compounded semaglutide "$99/mo*" and compounded tirzepatide "$199/mo*", where "*Price includes medication only" and "An active Eden Membership is required ($39 for the first month, auto-renews at $99/month thereafter)". After the first month that is $198 a month for semaglutide and $298 for tirzepatide. The same page lists Ozempic, Mounjaro and Zepbound at $1,399 a month and Wegovy at $1,695. Eden's site still blocks an ordinary browser; the page was read through a rendering service.

What this page used to say

2026-09-13 — Eden's monthly price. Was: No price shown, because tryeden.com could not be read. Now: $198 a month for compounded semaglutide and $298 for tirzepatide: the $99 membership plus the medication.
2026-09-13 — Eden's minimum term. Was: A three-month minimum. Now: Month to month: "a subscription service that you can cancel anytime".
2026-09-10 — A price nobody could check since June. Was: $198–$298 a month, from a third-party report read on 10 June 2026. Now: No price.

Every correction on this site, dated →

How this monthly figure is built

$99membership — their pricing page

+ $99compounded semaglutide; compounded tirzepatide is $199 — source

$198a month, all in

Eden does not publish this total. Its own page quotes the membership only — medication is billed separately, so we add the two and show both sources.

What does Eden actually charge?

halfrx records Eden at $198–$298 a month all-in, added by halfrx on 2026-09-13 from the membership fee and the medication price it publishes separately. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. It runs month to month. It carries one flag on this site: FDA warning letter. It scores 4.5 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. It is cash only: no insurance is billed, so the figure above is the whole of it. The medication is compounded rather than FDA approved: a copy made under the pharmacy-compounding exemption, which is a legal status and not a quality claim. The program includes clinical care and dispensing rather than a prescription alone. The page rests on 2 cited sources, at least one of them a manufacturer, regulator or journal. Molecules: semaglutide, tirzepatide.

Tracked since 2026-06-10. The figure has changed since. Last corrected on 2026-09-13 — see what this page used to say, above.

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Compounding legal riskFDA warning letter

What is good about Eden?

+Month to month: Eden calls its membership "a subscription service that you can cancel anytime".[2]
+Both molecules available under one membership.[1]

What are the downsides of Eden?

−The membership auto-renews at $99 a month after a $39 first month, and the medication is billed on top: $99 for semaglutide, $199 for tirzepatide.[2]
−Compounded only — post-shortage supply risk applies.[1]

How this score is built

1.8/2.5Cost — $298/mo at maintenance (top of the published range, since no ongoing price is published), scored against the $129–$699 spread of every verified price we track
0.0/2.5Medication — compounded medication, which the FDA does not review and which a court order can stop
1.0/1What they supply — strongest molecule offered: semaglutide, tirzepatide
0.8/1Commitment — month-to-month
1.0/1Care around the prescription — coaching, titration support and insurance help included
0.0/2Conduct — −2.3: compounding legal risk −0.8, FDA warning letter −1.5

Capped at 4.5: an active regulator action or a failing BBB grade limits the score whatever else it earns.

The full formula →

Who compounds it

Names no compounding pharmacy anywhere this site could read. The site refuses every automated request, including a plain browser user agent, so nothing could be read. That is a fact about the site rather than about its disclosure. Read 2026-09-10 across none — the site refused every automated request. Every seller audited the same way →

The public record

Lawsuits, regulator actions, FDA warning letters and BBB grade, each with the document behind it. Is Eden legit? →

Sources

[1] GLP-1 Telehealth Price Report 2026secondary
[2] Eden weight-loss medications and membership, read 13 September 2026primary

Compare Eden with

vs Henry Meds

Visit Eden ↗

Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.

The registers and documents behind this page

The public record on Eden is the result of searching these. They are named so the search can be repeated.

Warning letters, U.S. Food and Drug Administration — The register searched for every seller on this site. A letter found here is linked from the seller's page to the original.
Cases and proceedings, Federal Trade Commission — The register searched for advertising and billing actions against a seller.
Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.